Huge demand for COVID-19 rapid antigen testing may face manufacturing constraints

Diagnostic firms are working to massively grow rapid antigen testing for the virus, and they are running up against equipment, materials and manufacturing constraints that will limit how much and how quickly capacity can be expanded.